BeiGene vs Editas Medicine
BeiGene vs Editas Medicine, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Editas Medicine on 42/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 42/100
- agent readiness: 50/100 against 39/100
- domain rating: 68/100 against 61/100
- funding raised: $358M against $210M
Editas Medicine
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | Editas Medicine |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2010 | 2013 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Editas Medicine |
|---|---|---|
| Employees | Not published | 185 |
| Open roles | 100 | Not published |
| Total funding | $358M | $210M |
| Latest round | Secondary Offering | Series B |
| Valuation | $15B | Not published |
| LinkedIn followers | Not published | 52,616 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Editas Medicine |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 42/100 |
| Traction | 40/100 | 60/100 |
| Team | 30/100 | Not published |
| Search visibility | 17/100 | 27/100 |
| Quality | 88/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 61/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Editas Medicine |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
BeiGene vs Editas Medicine: common questions
Which is better, BeiGene or Editas Medicine?
On our 0-100 score BeiGene rates higher (64/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BeiGene and Editas Medicine compare on the numbers?
BeiGene leads on our overall score (64/100 against 42/100), agent readiness (50/100 against 39/100), domain rating (68/100 against 61/100), funding raised ($358M against $210M).
Read the full BeiGene review and pricing or the Editas Medicine review and pricing. You can also browse other BeiGene alternatives we track.